Anesiva, Inc. - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Anesiva, Inc.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Anesiva, Inc.. The Group's principal activity is developing and commercializing of novel therapeutic treatments for pain management. The Groups' products are Adlea and Zingo. Adlea is a long-acting, site-specific, non-opioid analgesic, is being developed for moderate to severe pain, and has completed multiple Phase 2 trials in post-surgical, musculoskeletal and neuropathic pain and Phase 3 trials in bunionectomy and total knee arthroplasty (TKA, or total knee replacement surgery). Zingo (lidocaine hydrochloride monohydrate) powder intradermal injection system. Zingo employs a proprietary needle-free dispenser. It operates in the United States and other foreign countries.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report